Company: OSRH
Filing Date: 2025-01-29
Form Type: S-4/A
Source: 0001213900-25-007923
Chunk: 75

Company: OSR Holdings, Inc.
Filing Date: 2025-01-29
Form: S-4/A
Chunk 75
---
5, the most recent practicable date prior to the date of this proxy statement/prospectus and an aggregate market value of approximately $5,074,000 based upon the closing price of $11.80 per public unit on Nasdaq on January27, 2025, the Record Date; •the fact that the Sponsor has agreed to waive its rights to liquidating distributions from the Trust Account with respect to any shares of BLAC Common Stock (other than public shares) held by it if BLAC fails to complete an initial business combination by February14, 2025 (unless such date is extended in accordance with the Existing Governing Documents); •the fact that Kuk Hyoun Hwang, Jun Chul Whang and affiliates of the Sponsor have a financial interest in OSR Holdings. Mr. Hwang is the CEO and a director of BLAC and the Chairman of the Board of OSR Holdings. Mr. Hwang was previously the CEO of OSR Holdings from July 2019 until August 2021 and from December 2022 to August 2024. Mr. Whang is a director of BLAC. As such, Mr. Hwang, Mr. Whang and affiliates of the Sponsor who have a financial interest in OSR Holdings are incentivized to complete the Business Combination with OSR Holdings; •the fact that the Sponsor transferred 20,000shares of BLAC Common Stock to each of Dr. Reed, Dr. Chung, Mr. Park, Dr. Roberts and Mr. Euh, who are current and former BLAC directors for their board service, and Mr. Yoo for his service as BLAC’s Chief Financial Officer. The Sponsor additionally transferred 20,000 private placement warrants to each of Dr. Reed for his service as the former chairman of the board of directors of BLAC, Dr. Chung for his service as the former chair of the audit committee of BLAC, and Mr. Yoo for his service as BLAC’s Chief Financial Officer; •the fact that the Sponsor and BLAC’s officers and directors will lose their entire investment in BLAC and will not be reimbursed for any out -of-pocketexpenses, if any, if an initial business combination is not consummated by February14, 2025 (unless such date is extended in accordance with the Existing Governing Documents) and, as a result, the Sponsor and BLAC’s officers and directors may have a conflict of interest in determining whether OSR Holdings is an appropriate business with which to effectuate